Renovar captures $1.2M for product development
Renovar, Inc. has closed its second round of financing for a total of $1.22 million for the purpose of preparing its first clinical product, a urine-based test for kidney transplant patients, for Food and Drug Administration approval. The latest round of funding was led by...